PL370167A1 - Sposób wytwarzania ludzkich linii komórek beta - Google Patents

Sposób wytwarzania ludzkich linii komórek beta

Info

Publication number
PL370167A1
PL370167A1 PL02370167A PL37016702A PL370167A1 PL 370167 A1 PL370167 A1 PL 370167A1 PL 02370167 A PL02370167 A PL 02370167A PL 37016702 A PL37016702 A PL 37016702A PL 370167 A1 PL370167 A1 PL 370167A1
Authority
PL
Poland
Prior art keywords
human beta
pancreatic
beta cell
cell lines
producing human
Prior art date
Application number
PL02370167A
Other languages
English (en)
Inventor
Paul Czernichow
Raphael Scharfmann
Philippe Ravassard
Jacques Mallet
Original Assignee
Universite Paris 7-Denis Diderot
Centre National De La Recherche Scientifique (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Paris 7-Denis Diderot, Centre National De La Recherche Scientifique (Cnrs) filed Critical Universite Paris 7-Denis Diderot
Publication of PL370167A1 publication Critical patent/PL370167A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL02370167A 2001-10-19 2002-10-18 Sposób wytwarzania ludzkich linii komórek beta PL370167A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/981,750 US20030077256A1 (en) 2001-10-19 2001-10-19 Pancreas regeneration using embryonic pancreatic cells

Publications (1)

Publication Number Publication Date
PL370167A1 true PL370167A1 (pl) 2005-05-16

Family

ID=25528625

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370167A PL370167A1 (pl) 2001-10-19 2002-10-18 Sposób wytwarzania ludzkich linii komórek beta

Country Status (18)

Country Link
US (2) US20030077256A1 (pl)
EP (1) EP1456356B1 (pl)
JP (1) JP2005505635A (pl)
KR (1) KR20040080430A (pl)
CN (1) CN1662644A (pl)
AT (1) ATE452967T1 (pl)
BR (1) BR0213429A (pl)
CA (1) CA2463979A1 (pl)
DE (1) DE60234862D1 (pl)
GB (1) GB2397825B (pl)
HR (1) HRP20040446A2 (pl)
HU (1) HUP0600102A2 (pl)
IL (1) IL161468A0 (pl)
NZ (1) NZ532965A (pl)
PL (1) PL370167A1 (pl)
RU (1) RU2004115108A (pl)
WO (1) WO2003033685A2 (pl)
ZA (1) ZA200403646B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035546A2 (en) * 2005-09-15 2007-03-29 The Burnham Institute For Medical Research Methods for screening for compounds that modulate insulin promoter activity
JP5636192B2 (ja) * 2007-02-21 2014-12-03 エス・ア・エール・エル アンドセルＳａｒｌ Ｅｎｄｏｃｅｌｌｓ 糖尿病の診断のためのヒト膵臓β細胞株
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
EP3008168B1 (en) 2013-06-11 2020-02-19 President and Fellows of Harvard College Sc- cells and compositions and methods for generating the same
EP3234110B1 (en) 2014-12-18 2024-02-28 President and Fellows of Harvard College METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF
US10253298B2 (en) 2014-12-18 2019-04-09 President And Fellows Of Harvard College Methods for generating stem cell-derived beta cells and methods of use thereof
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
JP7428653B2 (ja) 2017-11-15 2024-02-06 バーテックス ファーマシューティカルズ インコーポレイテッド 島細胞製造組成物および使用方法
EP3833365A4 (en) 2018-08-10 2022-05-11 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
CN110029130A (zh) * 2019-04-24 2019-07-19 皖南医学院第一附属医院（皖南医学院弋矶山医院） 基于CRISPR/Cas9系统在Beta-TC-6细胞株中剔除Sidt2基因方法
CN120813682A (zh) * 2024-02-09 2025-10-17 智新浩正(上海)医药科技有限公司 用于制备内胚层干细胞和由其衍生的胰岛的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses

Also Published As

Publication number Publication date
EP1456356A2 (en) 2004-09-15
GB2397825A (en) 2004-08-04
CA2463979A1 (en) 2003-04-24
JP2005505635A (ja) 2005-02-24
ATE452967T1 (de) 2010-01-15
US20030219418A1 (en) 2003-11-27
NZ532965A (en) 2006-04-28
CN1662644A (zh) 2005-08-31
KR20040080430A (ko) 2004-09-18
RU2004115108A (ru) 2005-02-10
EP1456356B1 (en) 2009-12-23
DE60234862D1 (de) 2010-02-04
GB0411052D0 (en) 2004-06-23
WO2003033685A2 (en) 2003-04-24
HUP0600102A2 (en) 2006-05-29
HRP20040446A2 (en) 2005-04-30
BR0213429A (pt) 2004-11-09
IL161468A0 (en) 2004-09-27
GB2397825B (en) 2006-02-22
WO2003033685A3 (en) 2004-05-27
US20030077256A1 (en) 2003-04-24
ZA200403646B (en) 2005-01-26

Similar Documents

Publication Publication Date Title
GB2397825B (en) Method of producing human beta cell lines
AU2003208567A8 (en) Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
WO2008048663A3 (en) Novel process for devitalized/acellular tissue for transplantation
EP1098642A4 (en) METHODS OF TREATING MODULATED CONDITIONS WITH LACTOSYLCERAMIDE
TR199903142T2 (xx) Pankreas dokusu adac��� transplantasyonu i�in CD154 blokaj tedavisi.
AU6090799A (en) Transgenic c. elegans as a model organism for research into alzheimer's disease
EP1425297A4 (en) INSULATION OF NERVE STEM CELLS USING GANGLIOSIDES AND OTHER SURFACE MARKERS
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
ATE484576T1 (de) Chimäre bauchspeicheldrüse
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
AU2001245319A1 (en) Methods of treating diseases with activated protein c
IL137410A0 (en) A method for the production of transgenic plants using apical shoot tips
WO2004030628A3 (en) Adult bone marrow derived stem cells
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.
RU96122257A (ru) Способ лечения расстройств центральной нервной системы
GB9907048D0 (en) Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
FR2801900B1 (fr) Methode de production de cellules animales adherentes
DE59909197D1 (de) Verfahren zur auslösung von apoptose in zellen
WO2004078956A3 (en) Process for detaching confluent cells from two dimensional microsupports and its application for preparing transplants
MX9709748A (es) Uso de lineas celulares fetales neuro-derivadas para terapia de trasplante.
UA39614A (uk) Спосіб корекції функціонального стану міокарда у лабораторних тварин пізнього онтогенезу
ATE525463T1 (de) Genomisches tabaknikotindemethylaseklon und verwendung
UA42521A (uk) Спосіб лікування епілепсії